18F PSMA 1007 is a relatively novel tracer which seems to have advantages over 68Ga PSMA in terms of reduced renal excretion, better tumour to back ground ratio, and longer half-life. As with any imaging modality PSMA targeted imaging has equivocal findings, posing as a diagnostic dilemma. ...
Whole body tumor burden derived from baseline [ 18 F]-PSMA 1007 PET was quantified, including SUVmean, SUVmax, PSMA tumor volume (PSMA-TV) and total lesion PSMA (TL-PSMA = PSMA-TV*SUVmean). Baseline laboratory values (hemoglobin, C-reactive protein (CRP), lactate dehydrogenase (LDH), ...
We found significantly higher uptake in the blood pool of F18-PSMA-1007 scans compared to Ga68 –PSMA- 11 scans (p- value <0.001) as well as higher uptake in the spleen on the F18-PSMA-1007 scans compared to liver uptake on the Ga68 –PSMA- 11 scans (p- value <0.001). There ...